Methotrexate

Methotrexate is an odorless yellow to orange-brown crystalline powder. (NTP, 1992) It is a chemotherapy drug that interferes with DNA and RNA synthesis. Methotrexate is a member of pteridines, a monocarboxylic acid amide and a dicarboxylic acid. Among its listed roles, it functions as a antineoplastic agent, an antirheumatic drug, an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, a DNA synthesis inhibitor, an abortifacient, a dermatologic drug, an antimetabolite and an immunosuppressive agent. Functionally, it is related to L-glutamic acid. It is the conjugate acid of methotrexate(1-). It is grouped under the following drug class(es): Antineoplastic agents, Cytotoxics and Immunosuppressants. Its therapeutic use is listed as anti-cancer agents, anti-inflammatories, anti-psoriatic agents, antineoplastics and antirheumatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Rheumatrex, Amethopterin, Metatrexan, Hdmtx and Ledertrexate. Its PubChem CID is 126941.

CAS No 59-05-2
Molecular Formula C20H22N8O5
Molecular Weight 454.40 g/mol
Synonyms (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid

Frequently Asked Questions